Harsha Reddy Borra

Group Leader – Biosimilar Development at Accord Healthcare Limited, UK

Speaker

"Harsha Reddy Borra is a bioprocessing leader with over 18 years of experience in biologics development and manufacturing, spanning monoclonal antibodies, complex proteins, and advanced therapies such as viral vectors. He currently serves as Group Leader – Biosimilar development at Accord Healthcare, where he oversees bioprocess development and leads external manufacturing activities to support regulatory submissions and technology transfer to clinical and commercial manufacturing.
Harsha played a pivotal role in establishing a Biopharma Centre of Excellence that accelerates biologics development through the implementation of process automation, advanced analytics, and digital tools. His expertise includes establishing platform processes, applying advanced statistical and modeling approaches for process optimization and late-stage process characterization to define design space, and integrating PAT strategies to drive efficiency and regulatory compliance.
Over his career, Harsha has worked across diverse therapeutic platforms, including biologics, biosimilars, and cell and gene therapy modalities, contributing to multiple global programs from early development to commercial scale. He has supported biosimilar and novel biologics programs worldwide, building high-performing teams and advancing innovation in sustainable biomanufacturing."